(untitled)
Christina Yau(Hospital Authority), Adam L. Asare(Quantum Leap Healthcare Collaborative), Fabien Reyal(Université Paris Sciences et Lettres), Angela DeMichele(University of Pennsylvania), Tanya L. Hoskin(Mayo Clinic), David Cameron(Corewell Health), Jean Abraham(Cancer Research UK), Matthew P. Goetz(Mayo Clinic), Sonal Shad(University of California, San Francisco), Laura van ‘t Veer, Tessa G. Steenbruggen(The Netherlands Cancer Institute), Stephen B. Edge(American Society of Clinical Oncology), Jelle Wesseling(Leiden University Medical Center), Lajos Pusztai(Yale University), Marieke van der Noordaa(University of California, San Francisco), Janet Dunn(National Health Service), Maartje van Seijen(The Netherlands Cancer Institute), Marie Osdoit(University of California, San Francisco), Lorna Mackintosh(Western General Hospital), Judy C. Boughey(Mayo Clinic in Arizona), Andrew K. Godwin(The University of Melbourne), Stephen‐John Sammut(Cambridge University Hospitals NHS Foundation Trust), Diane De Croze(Institut Curie), Kathi Adamson, Marick Laé(Laboratoire National Henri Becquerel), Jeremy Thomas(Western General Hospital), Peter S Hall(University of Edinburgh), Sara López‐Tarruella(Instituto de Salud Carlos III), Kimberly Cole(Yale University), Jane Wei(University of California, San Francisco), Gabe S. Sonke(Oncode Institute), Priyanka Sharma(Chandigarh University), Kathy S. Albain(Loyola University Chicago), Larry Hayward(Western General Hospital), Kelsey Schwensen(University of Kansas Medical Center), Elena Provenzano(University of Cambridge), Laura Esserman(UCSF Helen Diller Family Comprehensive Cancer Center), Marı́a del Monte-Millán(Hospital General Universitario Gregorio Marañón), Vicente Valero(The University of Texas MD Anderson Cancer Center), Helena Earl(University of Cambridge), Carlos Caldas(University of Cambridge), John M.S. Bartlett(Edinburgh Cancer Research), Louise Hiller(University of Warwick), Miguel Martín(Hospital General Universitario Gregorio Marañón), Mi‐Ok Kim(Bristol-Myers Squibb (United States)), Fang Fan(University of Kansas Medical Center), A Graham(Western General Hospital), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Rebekah Gould(The University of Texas MD Anderson Cancer Center), Anne‐Sophie Hamy(Université Paris Cité)
Edinburgh Research Explorer
January 1, 2000
Cited by 353
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k